The DOI matches its Crossref record; 438 of the 438 references it cites were found in a registry or an index.
Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies
Open accessAbstract
Photodynamic therapy (PDT) has emerged as a promising alternative to conventional cancer therapies such as surgery, chemotherapy, and radiotherapy. PDT comprises the administration of a photosensitizer, its accumulation in tumor tissue, and subsequent irradiation of the photosensitizer-loaded tumor, leading to the localized photoproduction of reactive oxygen species (ROS). The resulting oxidative damage ultimately culminates in tumor cell death, vascular shutdown, induction of an antitumor immune response, and the consequent destruction of the tumor. However, the ROS produced by PDT also triggers a stress response that, as part of a cell survival mechanism, helps cancer cells to cope with the PDT-induced oxidative stress and cell damage. These survival pathways are mediated by the transcription factors activator protein 1 (AP-1), nuclear factor E2-related factor 2 (NRF2), hypoxia-inducible factor 1 (HIF-1), nuclear factor κB (NF-κB), and those that mediate the proteotoxic stress response. The survival pathways are believed to render some types of cancer recalcitrant to PDT and alter the tumor microenvironment in favor of tumor survival. In this review, the molecular mechanisms are elucidated that occur post-PDT to mediate cancer cell survival, on the basis of which pharmacological interventions are proposed. Specifically, pharmaceutical inhibitors of the molecular regulators of each survival pathway are addressed. The ultimate aim is to facilitate the development of adjuvant intervention strategies to improve PDT efficacy in recalcitrant solid tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
RETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
Lee, K., Zhang, H., Qian, D. Z., Rey, S., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909353106 · Cited by 451
RetractedIto, H., Duxbury, M. S., Benoit, E., Clancy, T. E., Zinner, M. J., Ashley, S. W., & Whang, E. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1177 · Cited by 133
RetractedHan, C. L., Michalopoulos, G. K., & Wu, T. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20560 · Cited by 129
RetractedPhotodynamic therapy for cancer
Dolmans, D. E. J. G. J., Fukumura, D., & Jain, R. K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1071 · Cited by 6,758
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 1×
“Intratumoral angiogenesis, endothelial cell proliferation, and matrix and vascular remodeling are modulated by HIF-1 via upregulation of VEGF, endothelin 1 (EDN1), plasminogen activator inhibitor 1 (PAI1, SERPINE1), (inducible) nitric oxide synthase 2 (NOS2), angiopoietin (ANGPT) 1 and 2, erythropoietin (EPO), and tra…”
BackgroundJaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 2×
“Since malignant tumors proliferate faster than the rate of neovascularization, most tumors are hypoxic in nature and constitutively activate HIF-1 [316].”
BackgroundMatrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“HIF-1 activation by hypoxia HIF-1α acts as an oxygen sensor in that it is constantly targeted for proteasomal degradation under normoxic conditions as a result of hydroxylation and subsequent polyubiquitination [295, 297, 302–305].”
BackgroundDougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., & Peng, Q. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.889 · Cited by 4,716
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
Gomer, C. J. (1988) · Cited by 4,174
The unfolded protein response: controlling cell fate decisions under ER stress and beyond
Hetz, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3270 · Cited by 4,093
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,382
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative Stress
Harding, H. P., Zhang, Y., Zeng, H., Novoa, I., Lu, P. D., Calfon, M., Sadri, N., Yun, C., Popko, B., Paules, R., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00105-9 · Cited by 3,323
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251 · cited 1×
“rendered dysfunctional during hypoxia [332] (Section 3.”
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Sterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051 · cited 1×
“all modes of cell death, intracellular molecules are released that, following their release, act as so-called damage-associated molecular patterns (DAMPs) [80].”
BackgroundNF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709
Photodynamic therapy and anti-tumour immunity
Castano, A. P., Mroz, P., & Hamblin, M. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1894 · Cited by 2,676
Self-citationSignal integration by JNK and p38 MAPK pathways in cancer development
Wagner, E. F., & Nebreda, Á. R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2694 · Cited by 2,586
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251194298 · Cited by 2,558
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1
Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., & Ichijo, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2596 · Cited by 2,377
International Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
Cellular response to oxidative stress: Signaling for suicide and survival*
Martindale, J. L., & Holbrook, N. J. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10119 · Cited by 2,297
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1209 · Cited by 2,242
Regulation of glutathione synthesis
Lu, S. C. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.005 · Cited by 2,116
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068 · cited 4×
“oxide, respectively, but also transfer oxygen to prolyl residues in the HIF-1α oxygen-dependent degradation domain (ODD) [312].”
BackgroundInfluentialLee, A.-H., Iwakoshi, N. N., & Glimcher, L. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7448-7459.2003 · Cited by 2,037
Mitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926 · cited 1×
“HIF-1 activation by ROS HIF-1α stabilization by hypoxiamediated PHD and FIH inactivation can also proceed through ROS-mediated deactivation of PHDs and FIH in a manner that is not necessarily dependent on intracellular oxygen tension [309–311].”
BackgroundWang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Smithers, D. W. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91184-9 · Cited by 1,791
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751 · cited 1×
“GSH can also react with oxidized cysteine residues, resulting in protein glutathionylation and subsequent cellular efflux via proteins of the MRP family [110].”
BackgroundAP-1 in cell proliferation and survival
Shaulian, E., & Karin, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204383 · Cited by 1,736
Nrf2–Keap1 defines a physiologically important stress response mechanism
Motohashi, H., & Yamamoto, M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.003 · Cited by 1,725 · cited 1×
“Upon exposure to sublethal oxidative stress, cells attempt to restore redox homeostasis through the upregulated production of antioxidants, detoxifying enzymes, as well as phase III drug transporters to mediate the efflux of potentially harmful oxidation products [86, 87].”
BackgroundHypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Salceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Semenza, G. L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.01.005 · Cited by 1,514
Bellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., Pouysségur, J., & Mazure, N. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00166-09 · Cited by 1,501
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · cited 1×
“During oxidative stress, the NRF2-binding domain of KEAP1 is oxidized at Cys273 and Cys288, resulting in impaired KEAP1 binding to NRF2 [96].”
BackgroundHeat shock factors: integrators of cell stress, development and lifespan
Åkerfelt, M., Morimoto, R. I., & Sistonen, L. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2938 · Cited by 1,455
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
Ciocca, D. R., & Calderwood, S. K. (2005) · Cell Stress & Chaperones · doi:10.1379/csc-99r.1 · Cited by 1,404
p38 MAP-Kinases pathway regulation, function and role in human diseases
Cuenda, A., & Rousseau, S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.010 · Cited by 1,400
Selective interaction of JNK protein kinase isoforms with transcription factors.
Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., Sluss, H. K., Dérijard, B., & Davis, R. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00636.x · Cited by 1,338
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Definition of type I and type II photosensitized oxidation
Foote, C. S. (1991) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1991.tb02071.x · Cited by 1,248 · cited 1×
“Two types of photochemical reactions can proceed from the T1 state: type I reactions are characterized by electron transfer from the photosensitizer to O2, yielding O2 •– [18–20].”
BackgroundMechanisms of Cell Protection by Heme Oxygenase-1
Gozzelino, R., Jeney, V., & Soares, M. P. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105600 · Cited by 1,241 · cited 1×
“HO-1 neutralizes certain types of ROS directly as well as oxidized metabolites (lipid radicals) indirectly by producing the antioxidant molecule bilirubin from heme [106, 107].”
BackgroundRegulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi, R. K., Mookerjee, B., Bhujwalla, Z. M., Sutter, T. R., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · PubMed · Cited by 1,230
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1821 · Cited by 1,214
Jiang, B. H., Semenza, G. L., Bauer, C., & Marti, H. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.4.c1172 · Cited by 1,213
O’Connor, A. E., Gallagher, W. M., & Byrne, A. T. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2009.00585.x · Cited by 1,191
Hawkey, C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12154-2 · Cited by 1,173
Chaperone machines for protein folding, unfolding and disaggregation
Saibil, H. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3658 · Cited by 1,169
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Grivennikov, S. I., & Karin, M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.005 · Cited by 1,160
Regulation of JNK signaling by GSTp
Adler, V. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1321 · Cited by 1,116
The American Journal of Physiology
(1897) · Science · doi:10.1126/science.6.146.590.a · Cited by 1,105
Photophysical and photobiological processes in the photodynamic therapy of tumours
Ochsner, M. (1997) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(96)07428-3 · Cited by 1,081
JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis
Lei, K., & Davis, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438011100 · Cited by 1,068
Stadtman, E. R. (2006) · Free Radical Research · doi:10.1080/10715760600918142 · Cited by 1,056
Huang, H.-C., Nguyen, T., & Pickett, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206911200 · Cited by 1,034
Lipid peroxidation: Physiological levels and dual biological effects
Niki, E. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.032 · Cited by 1,006
Survivin, cancer networks and pathway-directed drug discovery
Altieri, D. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2293 · Cited by 994
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988 · cited 1×
“By contrast, MMPs have been associated with reduced angiogenesis due to the generation of the antiangiogenic compounds angiostatin and endostatin during the degradation of plasminogen (MMPs 2, 3, 7, 9, and 12) and collagen XVIII (MMPs 3, 9, 12, 13, and 20), respectively [234].”
BackgroundRegulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967
Majumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964
Wang, Z., Jiang, H., Chen, S., Du, F., & Wang, X. (2012) · Cell · doi:10.1016/j.cell.2011.11.030 · Cited by 949
Photophysics and photochemistry of photodynamic therapy: fundamental aspects
Plaetzer, K., Krammer, B., Berlanda, J., Berr, F., & Kiesslich, T. (2009) · Lasers in Medical Science · doi:10.1007/s10103-008-0539-1 · Cited by 891
The Role of c-Jun N-terminal Kinase (JNK) in Apoptosis Induced by Ultraviolet C and γ Radiation
Chen, Y.-R., Wang, X., Templeton, D., Davis, R. J., & Tan, T.-H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31929 · Cited by 867
Stabilization of wild-type p53 by hypoxia-inducible factor 1α
An, W. G., Kanekal, M., Simon, M. C., Maltepe, E., Blagosklonny, M. V., & Neckers, L. M. (1998) · Nature · doi:10.1038/32925 · Cited by 827
Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., & Otomo, S. (1994) · Prostaglandins · doi:10.1016/0090-6980(94)90074-4 · Cited by 826
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.497 · Cited by 800 · cited 1×
“Moreover, PERK was essential for the immunogenicity of CT26 cells treated with hypericin-PDT in vivo [453].”
BackgroundThe role of the transcription factor CREB in immune function
Wen, A. Y., Sakamoto, K. M., & Miller, L. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001829 · Cited by 790
Cummins, E. P., Berra, E., Comerford, K. M., Ginouves, A., Fitzgerald, K. T., Seeballuck, F., Godson, C., Nielsen, J. E., Moynagh, P., Pouyssegur, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602235103 · Cited by 788
Hinz, M., Krappmann, D., Eichten, A., Heder, A., Scheidereit, C., & Strauss, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2690 · Cited by 788
Molecular mechanisms of Nrf2‐mediated antioxidant response
Li, W., & Kong, A. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20465 · Cited by 785
THE MAMMALIAN CARBOXYLESTERASES: From Molecules to Functions
Satoh, T., & Hosokawa, M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.257 · Cited by 758
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells
Sullivan, N. J., Sasser, A. K., Axel, A. E., Vesuna, F., Raman, V, Ramirez, N., Oberyszyn, T. M., & Hall, B. M. (2009) · Oncogene · doi:10.1038/onc.2009.180 · Cited by 757
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Rokavec, M., Öner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73531 · Cited by 753
Molecular effectors of multiple cell death pathways initiated by photodynamic therapy
Buytaert, E., Dewaele, M., & Agostinis, P. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.07.001 · Cited by 746
Catalá, A. (2009) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2008.09.004 · Cited by 745 · cited 1×
“The (per)oxidative modifications of phospholipids and membrane-embedded molecules by ROS lead to changes in membrane fluidity, permeability, phasetransition properties, and membrane protein functionality [47–60].”
BackgroundRegulation of protein function by S‐glutathiolation in response to oxidative and nitrosative stress
Klatt, P., & Lamas, S. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01601.x · Cited by 745
Role of JNK activation in apoptosis: A double-edged sword
LIU, J., & LIN, A. (2005) · Cell Research · doi:10.1038/sj.cr.7290262 · Cited by 738
Photodynamic Therapy in Oncology
Triesscheijn, M., Baas, P., Schellens, J. H. M., & Stewart, F. A. (2006) · The Oncologist · doi:10.1634/theoncologist.11-9-1034 · Cited by 737
McMahon, M. J., Itoh, K., Yamamoto, M. P., Chanas, S. A., Henderson, C. J., McLellan, L. I., Wolf, C. R., Cavin, C., & Hayes, J. D. (2001) · PubMed · Cited by 732
Regulation of hypoxia-inducible factor-1α by NF-κB
van Uden, P., Kenneth, N. S., & Rocha, S. (2008) · Biochemical Journal · doi:10.1042/bj20080476 · Cited by 729
High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
Schödel, J., Oikonomopoulos, S., Ragoussis, J., Pugh, C. W., Ratcliffe, P. J., & Mole, D. R. (2011) · Blood · doi:10.1182/blood-2010-10-314427 · Cited by 724
Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., & Green, D. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80054-4 · Cited by 721
Chang, L., Kamata, H., Solinas, G., Luo, J.-L., Maeda, S., Venuprasad, K., Liu, Y.-C., & Karin, M. (2006) · Cell · doi:10.1016/j.cell.2006.01.021 · Cited by 706
Griffith, O. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33504-x · Cited by 701
Interleukin-6 signaling pathway in targeted therapy for cancer
Guo, Y., Xu, F., Lu, T., Duan, Z., & Zhang, Z. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.04.007 · Cited by 686
Luna, M. C., Ferrario, A., Wong, S. S., Fisher, A. M., & Gomer, C. J. (2000) · PubMed · Cited by 681
Heat Shock Proteins 27 and 70: Anti-Apoptotic Proteins with Tumorigenic Properties
Garrido, C., Brunet, M., Didelot, C., Zermati, Y., Schmitt, E., & Kroemer, G. (2006) · Cell Cycle · doi:10.4161/cc.5.22.3448 · Cited by 676
The mRNA 5′ cap-binding protein eIF4E and control of cell growth
Sonenberg, N., & Gingras, A.-C. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80150-6 · Cited by 673
Interaction of reactive oxygen species with ion transport mechanisms
Kourie, J. I. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.1.c1 · Cited by 643
Reactive Oxygen Species Activate the HIF-1α Promoter Via a Functional NFκB Site
Bonello, S., Zähringer, C., BelAiba, R. S., Djordjevic, T., Hess, J., Michiels, C., Kietzmann, T., & Görlach, A. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000258979.92828.bc · Cited by 628
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2
Luong, C., Miller, A., Barnett, J., Chow, J., Ramesha, C., & Browner, M. F. (1996) · Nature Structural Biology · doi:10.1038/nsb1196-927 · Cited by 618
Rohwer, N., & Cramer, T. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.03.001 · Cited by 608
Vallabhapurapu, S., Matsuzawa, A., Zhang, W., Tseng, P.-H., Keats, J. J., Wang, H., Vignali, D. A. A., Bergsagel, P. L., & Karin, M. (2008) · Nature Immunology · doi:10.1038/ni.1678 · Cited by 608
Goossens, V, Grooten, J., De Vos, K., & Fiers, W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8115 · Cited by 596
THE JOURNAL OF BIOLOGICAL CHEMISTRY.
(1905) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1905.02510220045008 · Cited by 596
Heger, M., van Golen, R. F., Broekgaarden, M., & Michel, M. C. (2014) · Pharmacological Reviews · doi:10.1124/pr.110.004044 · Cited by 576
Self-citationControl of cell cycle progression by c-Jun is p53 dependent
Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Mohle-Steinlein, U., Tian, J., Karin, M., Angel, P., & Wagner, E. F. (1999) · Genes & Development · doi:10.1101/gad.13.5.607 · Cited by 574
Huot, J., Houle, F., Marceau, F., & Landry, J. (1997) · Circulation Research · doi:10.1161/01.res.80.3.383 · Cited by 567
Venugopal, R., & Jaiswal, A. K. (1998) · Oncogene · doi:10.1038/sj.onc.1202237 · Cited by 564
Cadet, J., Douki, T., & Ravanat, J.-L. (2008) · Accounts of Chemical Research · doi:10.1021/ar700245e · Cited by 555
On respiratory impairment in cancer cells
Weinhouse, S. (1956) · Science · doi:10.1126/science.124.3215.267 · Cited by 554
Castano, A. P., Demidova, T. N., & Hamblin, M. R. (2005) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/s1572-1000(05)00060-8 · Cited by 552
Self-citationNon-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
Ulrich, C. M., Bigler, J., & Potter, J. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1801 · Cited by 548
Arosio, P., & Levi, S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00842-0 · Cited by 542
Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
Hayes, J. D., McMahon, M., Chowdhry, S., & Dinkova-Kostova, A. T. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3221 · Cited by 539
Bloom, D. A., & Jaiswal, A. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307633200 · Cited by 525
From receptors to stress-activated MAP kinases
Ichijo, H. (1999) · Oncogene · doi:10.1038/sj.onc.1203129 · Cited by 524
Kim, Y.-S., Morgan, M. J., Choksi, S., & Liu, Z.-G. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.021 · Cited by 519
Bond, M., Fabunmi, R. P., Baker, A. H., & Newby, A. C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01034-5 · Cited by 512
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity.
Kong, D., Park, E. J., Stephen, A. G., Calvani, M., Cardellina, J. H., Monks, A., Fisher, R. J., Shoemaker, R. H., & Melillo, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1235 · Cited by 508
Song, H., Wang, R., Wang, S., & Lin, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409894102 · Cited by 504
Yadav, A., Kumar, B., Datta, J., Teknos, T. N., & Kumar, P. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0271 · Cited by 503
Matsuzawa, A., & Ichijo, H. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.12.011 · Cited by 502
Chu, W.-M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.10.014 · Cited by 497
Sakon, S., Xue, X., Takekawa, M., Sasazuki, T., Okazaki, T., Kojima, Y., Piao, J., Yagita, H., Okumura, K., Doi, T., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg379 · Cited by 497
Regulation and function of the JNK subgroup of MAP kinases
Minden, A., & Karin, M. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00018-8 · Cited by 484
Liu, Y. V., Baek, J. H., Zhang, H., Diez, R., Cole, R. N., & Semenza, G. L. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.001 · Cited by 478
Identification of Activating Transcription Factor 4 (ATF4) as an Nrf2-interacting Protein
He, C. H., Gong, P., Hu, B., Stewart, D., Choi, M. E., Choi, A. M. K., & Alam, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101198200 · Cited by 473
Regulation of angiogenesis by hypoxia-inducible factor 1
Hirota, K., & Semenza, G. L. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.12.003 · Cited by 464
Buchanan, F. G., Wang, D., Bargiacchi, F., & DuBois, R. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302474200 · Cited by 463
Lei, K., Nimnual, A., Zong, W.-X., Kennedy, N. J., Flavell, R. A., Thompson, C. B., Bar-Sagi, D., & Davis, R. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4929-4942.2002 · Cited by 463
Targeting heat shock proteins in cancer
Jego, G., Hazoumé, A., Seigneuric, R., & Garrido, C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2010.10.014 · Cited by 452
Wiggin, G. R., Soloaga, A., Foster, J. M., Murray-Tait, V., Cohen, P., & Arthur, J. S. C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2871-2881.2002 · Cited by 445
Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity
Atkins, C., Liu, Q., Minthorn, E., Zhang, S.-Y., Figueroa, D. J., Moss, K., Stanley, T. B., Sanders, B., Goetz, A., Gaul, N., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3109 · Cited by 443
HBXIP functions as a cofactor of survivin in apoptosis suppression
Marusawa, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg263 · Cited by 432
Cyclooxygenase isozymes and their gene structures and expression
Tanabe, T., & Tohnai, N. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00024-2 · Cited by 422
MAPKAP kinases — MKs — two's company, three's a crowd
Gaestel, M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1834 · Cited by 413 · cited 1×
“inhibits CDCs to stimulate proliferation despite DNA damage (reviewed in [383]).”
BackgroundLin, Y., Choksi, S., Shen, H.-M., Yang, Q.-F., Hur, G. M., Kim, Y. S., Tran, J. H., Nedospasov, S. A., & Liu, Z.-G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313141200 · Cited by 412
Xia, X., Lemieux, M. E., Li, W., Carroll, J. S., Brown, M., Liu, X. S., & Kung, A. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810067106 · Cited by 410
Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones
Garcı́a-Piñeres, A. J., Castro, V., Mora, G., Schmidt, T. J., Strunck, E., Pahl, H. L., & Merfort, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101985200 · Cited by 407
Terpenoids: natural inhibitors of NF-κB signaling with anti-inflammatory and anticancer potential
Salminen, A., Lehtonen, M., Suuronen, T., Kaarniranta, K., & Huuskonen, J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8103-5 · Cited by 406 · cited 2×
“Inhibition of NF-κB Terpenoids are NF-κB inhibitors with a variety of structures and various modes of action [272] (Table 1).”
BackgroundMitochondrial survivin inhibits apoptosis and promotes tumorigenesis
Dohi, T., Beltrami, E., Wall, N. R., Plescia, J., & Altieri, D. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422222 · Cited by 405
Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1
Lu, H., Dalgard, C. L., Mohyeldin, A., McFate, T., Tait, A. S., & Verma, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508718200 · Cited by 400
Bakiri, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.9.2056 · Cited by 398
Nrf2 the rescue: Effects of the antioxidative/electrophilic response on the liver
Klaassen, C. D., & Reisman, S. A. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.01.013 · Cited by 396
Circu, M. L., & Yee Aw, T. (2008) · Free Radical Research · doi:10.1080/10715760802317663 · Cited by 393
Fisher, G. J., Talwar, H. S., Lin, J., Lin, P., McPhillips, F., Wang, Z., Li, X., Wan, Y., Kang, S., & Voorhees, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2153 · Cited by 392
Carbon monoxide in biology and medicine
Ryter, S. W., & Otterbein, L. E. (2004) · BioEssays · doi:10.1002/bies.20005 · Cited by 392
Roulston, A., Reinhard, C., Amiri, P., & Williams, L. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10232 · Cited by 376
Iwamaru, A., Szymanski, S., Iwado, E., Aoki, H., Yokoyama, T., Fokt, I., Hess, K., Conrad, C., Madden, T., Sawaya, R., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210031 · Cited by 370
The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm
Zipper, L. M., & Mulcahy, R. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206530200 · Cited by 366 · cited 1×
“cytosol [94, 95].”
Evaluation of HIF-1 inhibitors as anticancer agents
Semenza, G. L. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.08.006 · Cited by 363 · cited 3×
“However, most HIF-1 inhibitors are rather unspecific and also target the upstream modulators of HIF-1α protein synthesis, of which imatinib (an inhibitor of breakpoint cluster region protein (BCR)-ABL [328]), gefitinib, erlotinib, and cetuximab (an inhibitor of EGFR [329]), and everolimus (an inhibitor of mTOR [330])…”
BackgroundThe IL-6/sIL-6R complex as a novel target for therapeutic approaches
Rose-John, S., Waetzig, G. H., Scheller, J., Grötzinger, J., & Seegert, D. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.613 · Cited by 360
MacKenzie, E. D., Selak, M. A., Tennant, D. A., Payne, L. J., Crosby, S., Frederiksen, C. M., Watson, D. G., & Gottlieb, E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01927-06 · Cited by 359 · cited 3×
“PHDs to inhibit HIF-1 regardless of intracellular oxygen tension [141].”
BackgroundInfluentialEmerging roles of ATF2 and the dynamic AP1 network in cancer
Lopez-Bergami, P., Lau, E., & Ronai, Z. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2681 · Cited by 350
MATTSON, M. P., PEDERSEN, W. A., DUAN, W., CULMSEE, C., & CAMANDOLA, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07824.x · Cited by 348
Mattson, M. P. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01188-0 · Cited by 344 · cited 1×
“The (per)oxidative modifications of phospholipids and membrane-embedded molecules by ROS lead to changes in membrane fluidity, permeability, phasetransition properties, and membrane protein functionality [47–60].”
BackgroundYu, R., Chen, C., Mo, Y.-Y., Hebbar, V., Owuor, E. D., Tan, T.-H., & Kong, A.-N. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004037200 · Cited by 340
The Nrf2–Keap1 defence pathway: Role in protection against drug-induced toxicity
Copple, I. M., Goldring, C. E., Kitteringham, N. R., & Park, B. K. (2008) · Toxicology · doi:10.1016/j.tox.2007.10.029 · Cited by 329
Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway
Storz, P. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg009 · Cited by 325
Chemical Genetic Analysis of the Time Course of Signal Transduction by JNK
Ventura, J.-J., Hübner, A., Zhang, C., Flavell, R. A., Shokat, K. M., & Davis, R. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.018 · Cited by 323
Wang, T., Arifoglu, P., Ronai, Z., & Tew, K. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101355200 · Cited by 311
Wang, X. J., Hayes, J. D., Henderson, C. J., & Wolf, C. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709483104 · Cited by 309
Koukourakis, M. I., Giatromanolaki, A. N., Skarlatos, J., Corti, L., Blandamura, S., Piazza, M., Gatter, K. C., & Harris, A. L. (2001) · PubMed · Cited by 309
Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities
Scheller, J., Garbers, C., & Rose-John, S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2013.11.002 · Cited by 308
Bidirectional regulation of NF-κB by reactive oxygen species: A role of unfolded protein response
Nakajima, S., & Kitamura, M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.020 · Cited by 307
Vascular Effects of Photodynamic Therapy
FINGAR, V. H. (1996) · Journal of Clinical Laser Medicine & Surgery · doi:10.1089/clm.1996.14.323 · Cited by 302
Kaidi, A., Qualtrough, D., Williams, A. C., & Paraskeva, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0425 · Cited by 300 · cited 5×
“In addition to transcriptional regulation by NF-κB, the PTGS2 gene that encodes COX-2 contains four HRE sequences in its promoter region, explaining its upregulation by HIF-1 under hypoxic or prooxidative conditions [201].”
BackgroundInfluentialTanabe, O., Akira, S., Kamiya, T., Wong, G. G., Hirano, T., & Kishimoto, T. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.11.3875 · Cited by 293
Increased Prolyl 4-Hydroxylase Domain Proteins Compensate for Decreased Oxygen Levels
Stiehl, D. P., Wirthner, R., Köditz, J., Spielmann, P., Camenisch, G., & Wenger, R. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601719200 · Cited by 289
Fingar, V. H., Wieman, T. J., Wiehle, S., & Cerrito, P. B. (1992) · PubMed · Cited by 289
Targeting Hsp90: small-molecule inhibitors and their clinical development
Taldone, T., Gozman, A., Maharaj, R., & Chiosis, G. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.015 · Cited by 284
Drummond, G. S., & Kappas, A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6466 · Cited by 279
Zhao, Q., & Lee, F. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8355 · Cited by 274
Interplay between HDAC3 and WDR5 Is Essential for Hypoxia-Induced Epithelial-Mesenchymal Transition
Wu, M.-Z., Tsai, Y.-P., Yang, M.-H., Huang, C.-H., Chang, S.-Y., Chang, C.-C., Teng, S.-C., & Wu, K.-J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.012 · Cited by 273
Mayerhofer, M., Valent, P., Sperr, W. R., Griffin, J. D., & Sillaber, C. (2002) · Blood · doi:10.1182/blood-2002-01-0109 · Cited by 273
Korbelik, M., Sun, J., & Cecic, I. (2005) · Cancer Research · doi:10.1158/0008-5472.1018.65.3 · Cited by 273
Zinc Protoporphyrin: A Metabolite with a Mission
Labbé, R. F., Vreman, H. J., & Stevenson, D. K. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.12.2060 · Cited by 270
HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy
WANG, X., CHEN, M., ZHOU, J., & ZHANG, X. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2399 · Cited by 269
JunD Protects Cells from p53-Dependent Senescence and Apoptosis
Weitzman, J. B., Fiette, L., Matsuo, K., & Yaniv, M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00109-x · Cited by 269
Liposomes as membrane model for study of lipid peroxidation
Chatterjee, S. N., & Agarwal, S. (1988) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(88)90011-1 · Cited by 267
Role of β-arrestin 1 in the metastatic progression of colorectal cancer
Buchanan, F. G., Gorden, D. L., Matta, P., Shi, Q., Matrisian, L. M., & DuBois, R. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510562103 · Cited by 267
Heme Oxygenase-1: Redox Regulation and Role in the Hepatic Response to Oxidative Stress
Bauer, M., & Bauer, I. (2002) · Antioxidants & Redox Signaling · doi:10.1089/152308602760598891 · Cited by 264
Yin, Z., Ivanov, V. N., Habelhah, H., Tew, K. D., & Ronai, Z. A. (2000) · PubMed · doi:10.7916/d8571b9j · Cited by 264
Stimulation of anti-tumor immunity by photodynamic therapy
Mroz, P., Hashmi, J. T., Huang, Y.-Y., Lange, N., & Hamblin, M. R. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.81 · Cited by 261
Self-citationFujino, G., Noguchi, T., Matsuzawa, A., Yamauchi, S., Saitoh, M., Takeda, K., & Ichijo, H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00227-07 · Cited by 261
Emerling, B. M., Platanias, L. C., Black, E., Nebreda, A. R., Davis, R. J., & Chandel, N. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.4853-4862.2005 · Cited by 258
Mroz, P., Pawlak, A., Satti, M., Lee, H., Wharton, T., Gali, H., Sarna, T., & Hamblin, M. R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.005 · Cited by 257
Self-citationAntiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario, A., von Tiehl, K., Rucker, N., Schwarz, M. A., Gill, P. S., & Gomer, C. J. (2000) · PubMed · Cited by 256
The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses
Bracken, C. P., Whitelaw, M. L., & Peet, D. J. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-2370-y · Cited by 251
A20: from ubiquitin editing to tumour suppression
Hymowitz, S. G., & Wertz, I. E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2775 · Cited by 247
Kapitulnik, J. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002832 · Cited by 239
de Almagro, M. C., & Vucic, D. (2012) · PubMed · Cited by 237
Cited by
Antimicrobial photodynamic inactivation: a bright new technique to kill resistant microbes
Hamblin, M. R. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.06.008 · Cited by 775
Self-citationConquering the Hypoxia Limitation for Photodynamic Therapy
Wan, Y., Fu, L., Li, C., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202103978 · Cited by 705
Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies
Xie, J., Wang, Y., Choi, W., Jangili, P., Ge, Y., Xu, Y., Kang, J., Liu, L., Zhang, B., Xie, Z., et al. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01370f · Cited by 522
Karimi, M., Sahandi Zangabad, P., Ghasemi, A., Amiri, M., Bahrami, M., Malekzad, H., Ghahramanzadeh Asl, H., Mahdieh, Z., Bozorgomid, M., Ghasemi, A., et al. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b00371 · Cited by 500
Self-citationPhotodynamic therapy in cancer treatment - an update review
Dos Santos, A. F., De Almeida, D. R. Q., Terra, L. F., Baptista, M. S., & Labriola, L. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.83 · Cited by 446
Metadata
- Authors
- Broekgaarden, M., Weijer, R., van Gulik, T. M., Hamblin, M. R., & Heger, M.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2015-10-29
- Volume
- 34
- Issue
- 4
- Pages
- 643-690
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1833716810
- Cited by
- 255
- References
- 438
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.